Eustachian tube dysfunction persist, the tympanic membrane is weakened, which increases the likelihood of an atelectatic ear or cholesteatoma formation. The presence of mucin prevents the transmission of sound waves from the middle ear to the inner ear, leading to conductive hearing loss. Pseudomonas aeruginosa and Staphylococcus aureus are the most common pathogens implicated in CSOM. [18] [19] [20] [21] Host resistance against pathogens depends on a complex interplay of innate and adaptive immune mechanisms. The innate immune system provides a first-line, non-specific defense mechanism, in contrast to the adaptive immune process, which is pathogen-specific and requires sensitization. Innate immunity also stimulates and modulates adaptive immune responses. The present review is focused on the role of the innate immune system in OM, specifically the role of middle ear epithelial cells, neutrophils, macrophages, fibroblasts, mast cells, and natural killer cells in protecting the middle ear against pathogens (Figure 1 ). The innate immune system detects microbial infection and uses pattern recognition receptors (PRRs) to recognize the molecular signature of pathogens, known as pathogen-associated molecular patterns (PAMPs). 22 PRRs include toll-like receptors (TLRs), cytoplasmic nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs), retinoic acid-inducible gene (RIG-I), and C-type lectin receptors (CLRs). The role of these PRRs in OM is also discussed.
Epithelial cells
The epithelial lining of the middle ear contains several key defense mechanisms including the presence of the mucociliary apparatus, trapping function of mucous glycoproteins and surfactants, ability to secrete innate defense molecules such as defensins, interferons, lactoferrin, and nitric oxide, and antibody production through the adaptive immune response. Middle ear epithelial cells also express PRRs like TLRs, which help in sensing pathogens through PAMPs. 22 
Defensins
The middle ear epithelial cells primarily release beta defensins, which are cationic proteins with antimicrobial function against a wide range of viruses, bacteria, fungi, and protozoa. 23 Their major antimicrobial mechanism is thought to be through the formation of a pore into the microbial membrane. However, some defensins are known to stimulate pro-inflammatory cytokines/chemokines, to act as chemoattractants for neutrophils, mast cells, T cells, and dendritic cells, and to directly inhibit bacterial toxins. 23 The up-regulated expression of mouse b-defensins 2, 3, and 4 has been demonstrated in the tubotympanums in experimental OM, while no such upregulation was seen in the middle ears of healthy controls. 24 Human b-defensin 2 (HBD2) is seen to be up-regulated in the middle ear response to bacteria and cytokines like non-typeable Haemophilus influenzae (NTHi) and interleukin (IL)-1a. 25, 26 HBD2 expression occurs in response to NTHi binding to toll-like receptor 2 (TLR2) and subsequent activation of a toll/IL-1 receptor MyD88-IRAK1-TRAF6-MKK3/6-p38 mitogen activated protein (MAP) kinase signal transduction pathway. 25, 26 Betadefensin 2 production has been demonstrated to be greatest when the p38 MAP kinase pathway acts synergistically with the MyD88-independent Raf-MEK1/2-ERK MAP kinase pathway stimulated by IL-1a. 25, 26 In addition, the b-defensin 2 production in epithelial cells is up-regulated with exposure to tumor necrosis factor alpha (TNF-a) and lipopolysaccharide (LPS). 27 The recombinant human b-defensin 3 (rhBD-3) plays a critical role in eliminating NTHi, and its function has been shown to be inhibited by biofilms. 28 Figure 1 . Middle ear innate immunity. The middle ear is lined by epithelial cells, which can provide protection by secreting antimicrobial molecules, or through toll-like receptors (TLRs). The middle ear also possesses innate immune cells such as neutrophils, macrophages, dendritic cells, mast cells, and natural killer cells providing defense against intruding pathogens.
SPLUNC1
Another important molecule that has been demonstrated to play a role in OM is SPLUNC1. It is a predominant component of the surface liquid that covers the mucosal surfaces of the human respiratory tract. SPLUNC1 has broad-spectrum antimicrobial activity and reduces biofilm formation by P. aeruginosa, supporting the assertion that this molecule functions in host defense. [29] [30] [31] SPLUNC1 can also act as a chemoattractant that recruits macrophages and neutrophils to the site of infection. 32 It functions as a surfactant to reduce surface tension at an air-liquid interface in the upper airway, including the Eustachian tube, and acts as a liquid-volume sensor to regulate membrane ion channels. Although the loss of SPLUNC1 has been shown not to impact the survival of NTHi, it has been found to be essential in the maintenance of middle ear fluid pressure and efficient mucociliary clearance. This finding has also been demonstrated in a chinchilla model that lacks the expression of SPLUNC1 ortholog. 33 
Other antimicrobial molecules
Several other antimicrobial molecules from epithelial cell secretions in OM have been investigated. The administration of apolactoferrin, the iron-free form of lactoferrin, was shown to significantly reduce bacterial counts and the number of inflammatory cells in a chinchilla model of S. pneumoniae-induced OM. 34 It has also been shown that mammalian chitinase and chitotriosidase are overexpressed in adenoidal histiocytes and vascular endothelial cells in OM. 35 This suggests that dysregulation of chitin-containing pathogens may play a role in OM.
Mucin
Mucins are high molecular weight glycoproteins that are implicated in a variety of pathological conditions. 36, 37 Variation in the quantity and character of middle ear secretions, and specifically mucin secretion, is known to be important in the pathophysiological mechanisms of OM. Mucins are the only component of middle ear effusions responsible for its viscous properties, and an over-production of these viscous mucins can prevent normal mucociliary clearance.
The persistent accumulation of mucin in the middle ear cavity is likely to involve extensive proliferation of mucous cells and associated mucosal metaplasia. Mice middle ear infected with NTHi resulted in mucosal metaplasia and overexpression of Cxcl2, a major inflammatory cell recruiter, thus delaying resolution of infection. 38 P. aeruginosa exotoxin A promotes metaplasia, necrosis, and apoptosis of epithelial cells of the middle ear, thus exposing the submucosal and lamina propria layers, perhaps leading to inner ear infection and damage. 39 Molecular analyses have shown that TNF-a and retinoic acid act synergistically with Math1, a transcription factor essential for differentiation of epithelial cells into mucosal cells, to transform mouse middle ear epithelial cells into metaplastic mucous-like cells. 40 The overproduction of mucin by epithelial cells leads to CSOM. In humans, 19 mucin genes have been identified. Among these, MUC2, MUC5AC, and MUC5B have been shown to play an important role in the pathogenesis of OM. [41] [42] [43] Abnormally high levels of mucin proteins have been demonstrated in middle ear effusions of CSOM patients. 44 This presence of mucin prevents the transmission of sound waves from the middle ear to the inner ear, hence leading to conductive hearing loss. However, the molecular mechanisms underlying mucin overproduction by human middle ear epithelial cells (HMEECs) during CSOM are still unknown. We have observed, using scanning electron microscopy, that P. aeruginosa binds and adheres to HMEECs ( Figure 2 ). 45 Transmission electron microscopy demonstrated P. aeruginosa internalization inside HMEECs enclosed in membranebound vacuoles ( Figure 3 ). 45 However, how this adhesion and subsequent internalization leads to mucin up-regulation needs to be explored in future studies.
Lysozyme
Various cells of the human airway, including surface epithelial cells, have been shown to produce lysozyme, an antimicrobial innate immune molecule that degrades the peptidoglycan of the bacterial cell wall. 46 It is particularly found in the tubotympanum of mammals and plays a significant role in OM. 47 Lysozyme and HBD2 have synergistic killing effects against S. pneumoniae. 48 Lysozyme M knock-out mice are more susceptible to S. pneumoniae infection, thus suggesting the role of lysozyme in host defense. 49 
Toll-like receptors (TLRs)
There are at least 10 different TLRs found on the surface of epithelial cells of the human middle ear. TLRs contain an N-terminal extracellular leucine-rich repeat domain and a cytoplasmic toll/IL-1 receptor domain. TLR molecules provide protection against infection by recognizing intruding pathogens through their invariant PAMPS and then mobilizing appropriate immune defenses. 50, 51 The activation of most TLRs results in downstream activation of the mitogen activated protein kinase (MAPK) or the nuclear factor kappa B (NF-kB)-dependent cell signaling cascades, thus leading to further activation of immune responses (Figure 4 ). 52 In OM, NTHi is associated with several molecular patterns that function as TLR ligands. NTHi cell surface peptidoglycans and the associated proteins such as outer membrane protein (OMP) P6 serves as a ligand for TLR2. 53 Another notable example is lipooligosaccharide (LOS), which serves as a ligand for TLR2 and TLR4. 54 Not surprisingly, polymorphisms in the gene encoding for TLR4 have been associated with recurrent acute OM. 55 When infected with NTHi, TLR4 knock-out mice had a worse mucosal immune response as compared to wild-type mice. 56 These TLR4 knock-out mice had inferior immune responses with regards to mucosal IgA, systemic IgG, and Th1 cells. 56 NTHi and its various immunogenic molecules have been shown not only to directly activate TLR, but to up-regulate TLR2 gene expression in middle ear epithelial cell lines. 57 Patients with chronic middle ear disease like CSOM have been shown to exhibit lower mRNA levels of TLR4, TLR5, and TLR7 than a control group. 58 A recent report has further confirmed these findings, demonstrating lower mRNA and protein levels of TLR2, TLR4, and TLR5 in middle ear mucosa of CSOM patients. 59 The down-regulation of TLR expression during OM can lead to inefficient host defense in the middle ear. This can cause repeated infections and persistent inflammations, eventually leading to recurrent, persistent suppurative chronic middle ear diseases.
DNA sensors
Microbial and other forms of non-self DNA can also serve as PAMPs. 60 DNA sensors like TLR9 recognize unmethylated cytidine-phosphate-guanosine (CpG) motifs that are common in bacterial, but not mammalian, DNA. 61 TLR9 access to bacterial DNA is further enhanced by the nuclear high-mobility group box 1 protein (HMGB1). 62 Like other TLRs, TLR9 utilizes the TLR adaptor molecule MyD88, which leads to the production of proinflammatory cytokines via the activation of NF-kB ( Figure 4 ). 61 Besides TLR9, there are six intracellular receptors that have also been implicated in cytosolic DNA sensing in the innate immune response. These include DNA-dependent activator of interferon (IFN) regulatory factors (DAI) (also called Z-DNA binding protein 1, ZBP1), absent in melanoma 2 (AIM2), RNA polymerase III (Pol III), leucine-rich repeat (in Flightless I) interacting protein-1 (Lrrfip1), DExD/H box helicases (DHX9 and DHX36), and most recently, the IFN inducible protein IFI16. [63] [64] [65] [66] [67] [68] [69] [70] These DNA sensors play a crucial role in the pathogenesis of OM. OM-prone children show lower TLR9 mRNA levels as compared to the non-prone group. 71 Decreased TLR9 mRNA expression has also been demonstrated in patients with OM with effusion (OME) with confirmed bacteria in the middle ear like S. aureus, S. pneumoniae, Bacillus spp, and NTHi. 72 TLR9 knock-out mice (TLR9 À/À ) demonstrated prolonged and enhanced morphological signs of mucosal hyperplasia and inflammation in the middle ear, as well as a delay in bacterial clearance and OM recovery compared to wild-type animals in a murine model of OM induced by NTHi. 73 There was modest upregulation of TLR9 signaling genes in this OM mouse model, which corroborated with the protein levels in both middle ear mucosal cells and infiltrating leukocytes. However, there was dramatic up-regulation in genes known to be regulated by CpG DNA, as well as those involved in DNA sensing by DAI, Pol-III, and AIM2. 73 These results suggest that bacterial DNA sensing by the innate immune system plays an important role in OM resolution and recovery. However, further studies are warranted to explore the role of bacterial DNA in the pathogenesis and resolution of OM. The availability of gene deletion models for other DNA receptors will help in characterizing the role of DNA sensors in OM.
NOD-like receptors (NLRs) and RIG-I-like receptors (RLRs)
When pathogens bypass the membrane-associated PRRs like TLRs, they encounter cytoplasmic PRRs such as caspase activation and recruitment domain (CARD) helicases like RLRs and NLRs. 74, 75 A wide variety of cells such as macrophages and dendritic cells, as well as middle ear epithelial cells, express these PRRs. 76 RLRs are expressed ubiquitously at low levels, and their expression is induced by treatment with type I IFN or a viral infection. 77 RLRs like melanoma differentiation-associated 5 (MDA5) and RIG-I can recognize dsRNA or ssRNA with 5 0 triphosphate ends (ppp-ssRNA). They contain an RNA helicase domain critical for RNA recognition and two CARDs critical for initiating downstream signaling pathways. 78 NLRs are a group of evolutionarily conserved intracellular PRRs that play a vital role in innate immunity. 76 There are 23 members of NLRs out of which NOD1 and NOD2 have gained a lot of attention in the pathogenesis of OM. 74 RLRs and NLRs like NOD1 and NOD2 have the ability to initiate and support robust immune responses through the formation of inflammasomes and the activation of NF-kB, leading to the production of inflammatory cytokines (Figure 4 ). 76 NLRs and RIG-I play an important role during OM. Patients with OME show significantly lower levels of NOD1 and NOD2, as well as RIG-I. 79 These decreased PRR expression levels may be associated with the development of recurrent OME, demonstrating the protective role of NOD1, NOD2, and RIG-I in OM.
C-type lectin receptors (CLRs)
CLRs are a diverse family of soluble and transmembrane proteins that bind carbohydrates through one or more carbohydrate recognition domains, or which possess structurally similar Ctype lectin-like domains that may not necessarily recognize carbohydrate ligands. 80, 81 CLRs are divided into 17 groups based on features including phylogeny and structure. 82 Multiple members of the CLR family are considered to be PRRs due to their ability to recognize pathogen-associated molecules and induce intracellular signaling pathways that regulate the immune response. 83 The adaptor molecules in CLR signaling like Bcl-10 are crucial in innate resistance to bacterial infection and LPS signaling. 84 Bcl-10 is an intracellular NF-kB activator with a CARD that can form homo-oligomers through CARD-CARD interactions under appropriate conditions. 85 The other CLR members such as Dec-205 are involved in endocytosis and antigen presentation. 86 Triggering receptor expressed on myeloid cells 1 (Trem-1) CLR is up-regulated by bacterial LPS and helps in the activation of neutrophils and monocytes. 87 It plays a crucial role in the production of cytokines and chemokines as well as up-regulating adhesion molecules. 88 The role of these CLRs in the pathogenesis of OM has only begun to be elucidated. Patients with OME demonstrate higher mRNA levels of CLRs or CLR adaptor molecules such as dectin-1, MR1, MR2, DC-SIGN, Syk, Card-9, Bcl-10, Malt-1, Src, Dec-205, galectin-1, Tim-3, Trem-1, and DAP-12 in middle ear effusions. 89 The increased expression of CLRs and their adaptor molecules like Dec-205, Bcl-10, Tim-3, and Trem-1 mRNA have also been observed in chronic OM with cholesteatoma. 90 However, further studies are warranted to assess the protein expression of CLRs and their association with the pathogenesis of OM.
Neutrophils
Neutrophil involvement in OM has been a topic of increased interest over the past few years. Neutrophils, or polymorphonuclear granulocytes (PMNs), are the most abundant leukocytes and form the first line of defense against invading pathogens. 91 Recent research focusing on acute OM caused by NTHi demonstrated the formation of neutrophil extracellular traps (NETs) by PMNs in response to bacterial infection. 92 NETs are characterized by a double-stranded DNA lattice decorated with histones and elastase. [93] [94] [95] NETs are hypothesized to determine bacterial persistence (rather than clearance) by providing a niche within the middle ear chamber. NETs were found to be positively correlated with higher bacterial loads within middle ear fluids and surfaceattached communities in the chinchilla infection model. 96 The inability of NETs to clear otopathogens may contribute to establishing stable bacterial communities in the middle ear. Bacteria entangled in DNA stranding from NETs can contribute to effusion viscosity, one of the hallmarks of CSOM. This may also lead to insufficient penetration of antibiotics and hence failure to clear infection.
TLRs are also seen to be important in bacterial clearance by neutrophils during OM. TLR 2, 4, 5, and 9 mRNA expression is upregulated in neutrophils infected with M. catarrhalis with and without pili. 97 When TLR4 is non-functional in C3H/HeJ mice, NTHi infections are prolonged and phagocytosis as well as phagosome maturation in PMNs are impaired. 98 Thus, TLR4 appears to be intimately involved in the bactericidal function of PMNs and plays a vital role in eradicating NTHi infection in the middle ear.
Macrophages
Macrophages play a central role in innate immunity of the middle ear. 99 Macrophages have been shown to be a major cellular component of middle ear effusions present in humans. 100 Middle ear macrophages harvested from human effusions produce suppressive factors that lead to a hyporesponsiveness of lymphocytes to several mitogens. 101 This may contribute to the chronicity of OM by promoting ineffective elimination of bacteria. It has also been shown that macrophages recruited to the middle ear are functional and capable of discriminate phagocytosis and intracellular killing of bacteria. 102 However, S. pneumoniae types 14 and 19F, which are associated with the highest relapse frequency in cases of acute OM, were found to be the most resistant to phagocytosis. The clinical isolates of NTHi obtained from children with OM have also been demonstrated to survive in macrophages. 103 This ability may enable NTHi to gain an intracellular niche within its host and contribute to the observed frequency of recurrent infection. The relative importance of macrophage function in defense of the middle ear, therefore, may be dependent on the causative agent. Inefficient phagocytosis or intracellular killing and/or incomplete digestion of bacteria by middle ear phagocytes could lead to bacterial antigens being trapped in the middle ear. This could promote middle ear effusions by a sustained release of inflammatory mediators or immune injury. Further studies are warranted to characterize the role of bacterial and host factors leading to the survival of OM pathogens inside macrophages.
Dendritic cells/Langerhans cells
Dendritic cells (DCs) are antigen-presenting cells (APCs) and play an important role in the orchestration of immune responses. 104, 105 The epithelial residents of DCs are Langerhans cells (LCs), which serve as the 'sentinels' of the mucosa. 106 LCs are capable of engaging and internalizing a wide variety of pathogens. The normal tympanic membrane in the ear contains abundant DCs/ LCs. 107 These tympanic membrane DCs/LCs have also been shown to have the potential to migrate and to efficiently sensitize T cells. 107 A significant increase in the number of DCs/LCs in CSOM as compared with that in the normal tympanic membrane has been reported in animal models and human patients. 108, 109 An increase in the size and more branching of LCs has also been observed in OM. 110 However the exact function of DCs/LCs in the middle ear under normal and OM conditions has yet to be elucidated.
Fibroblasts
Fibroblasts are the most common cells of connective tissue and synthesize the extracellular matrix and collagen. They are 'sentinel cells' capable of producing various immune modulators such as peptide growth factors, cytokines, chemokines, and low molecular weight inflammatory mediators. In OM, fibroblasts are largely responsible for the architectural changes found in the middle ear. These changes include hyperplasia of the mucosal epithelium as well as subepithelial connective tissue. [111] [112] [113] [114] During OM, the middle ear mucosa proliferates into a pseudostratified ciliated secretory columnar epithelium. There is significant neovascularization, which not only allows for increased thickness but also provides a means for leukocyte infiltration. This process is a potential factor in middle ear effusion and subsequent tissue edema formation. During NTHi-induced OM, it appears that the up-regulation of fibroblast and vascular endothelial growth factors (FGFs and VEGFs) is responsible for the angiogenesis associated with these changes. 115 It has also been observed that VEGF is a significant mediator of vascular permeability and therefore middle ear effusion. Further studies are warranted to understand the role of fibroblasts and underlying signaling mechanisms responsible for angiogenesis during OM.
Mast cells
Mast cells are an integral part of innate immunity and are deeply involved in the pathogenesis of OM. [116] [117] [118] [119] [120] Mast cells are predominantly found in the pars flaccida compared to the pars tensa of the tympanic membrane in the middle ear. 121, 122 They have also been shown to be distributed throughout the tubotympanum in guinea pigs, in a decreasing gradient from the pharyngeal to the tympanic orifices, and in the ciliated epithelium and highly vascularized parts of the middle ear. 123 High densities of mast cells have also been found in the floor of the rat tympanic bulla. 124 Mast cell involvement in OM has been strongly linked to histamine release. High levels of histamine in middle ear effusions in various clinical studies and animal models have been correlated with mast cell proliferation. [125] [126] [127] [128] In fact, increased histamine release and thus mast cell proliferation, has been linked to mast cells originating from the adenoids, as described in the adenoid mediator release theory. [129] [130] [131] One study found that the mast cell count is higher in combined OME and adenoiditis than adenoiditis alone. A greater hearing loss has been correlated with mast cell density, thus revealing the complex nature of mast cell involvement in OME. 132 Mast cells appear to be involved in the longer clinical courses of CSOM. 133 But the relationship between mast cells and bacterial infection in CSOM has not been entirely conclusive. Increased mast cell activity has been shown in CSOM in which S. aureus and P. aeruginosa are implicated, and in acute otitis media. [134] [135] [136] Yet Pajor et al. failed to show an increased density of mast cells in CSOM due to bacterial infection. 133 Ebmeyer et al. demonstrated that NTHi infection causes middle ear mucosal inflammatory changes in both wild-type and mast cell-deficient mice. 137 However the early response was significantly blunted in mast cell-deficient mice. It has been suggested that mast cells may be involved in the bone resorption observed in CSOM. 138, 139 Bone resorption is the process by which osteoclasts break down bone and release minerals, resulting in a transfer of calcium from bone fluid to the blood. It is an important aspect of CSOM contributing to many complications of this disease such as ossicular erosion.
Natural killer cells
Natural killer (NK) cells are effector lymphocytes of the innate immune system. 140 While the importance of NK cells in innate immune protection against tumors or viral infections is well documented, their role in providing protection against bacteria is still emerging. Jecker et al. demonstrated that although in healthy rat middle ears there was no local proliferation of immunecompetent cells, approximately 15% of NK cells at day 5 of acute OM were newly formed and likely to have been due to local proliferation, while the remaining portion represented those migrated from the outside mucosa. 141 An increase in the number of NK cells in the serum of CSOM children suggests a possible role of these lymphocytes in protecting the middle ear against infection. 142 However, further studies are warranted to explore the role of NK cells in the pathogenesis of acute and chronic OM.
Concluding remarks
OM is an important public health problem with substantial economic and societal costs. It is a major global cause of hearing impairment. Hearing loss caused by OM leads to speech difficulties, attention deficit, language learning problems, and reading problems, as well as cognitive and behavioral disorders in children. In the past several years, considerable advances have been made in understanding the role of innate immunity in the pathogenesis of AOM. However, very few studies are available regarding the role of innate immunity in CSOM. The rise in the incidence of CSOM cases, emergence of antibiotic resistance, and potential ototoxicity of antibiotics has created an immediate incentive to focus research studies in this area so that novel therapeutic strategies may be developed. There is a need to explore the role of PRRs like TLRs, NLRs, RLRs, and CLRs in the pathophysiology of CSOM. Understanding the role of innate immunity in the pathogenesis of OM, especially CSOM, will open up new avenues to design effective non-conventional therapies against the disease. The antimicrobial innate immune molecules (AIIMs) like b-defensins will be of immense use to treat OM caused by antibiotic-resistant strains of otopathogens. Implementing these approaches could decrease physician visits, healthcare costs, antibiotic use, and surgery, and at the same time increase quality of life for many OM patients.
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